Freeline Therapeutics Holdings plc (FRLN) Financials
Stock symbol FRLN is outdated, potentially delisted? Maybe it is available on other exchange?
FRLN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 49.2 million | 19.2 million |
| 2023-06-30 | 62.7 million | 20.6 million |
| 2023-03-31 | 86.6 million | 34.2 million |
| 2022-12-31 | 86.6 million | 34.2 million |
FRLN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -8.7 million | 895000 |
| 2023-06-30 | -17.5 million | 1.1 million |
| 2023-03-31 | -23.7 million | 1.0 million |
| 2022-12-31 | -23.7 million | 1.0 million |
FRLN Net Income
No data available :(
FRLN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 29.5 million | - | 4.0 million |
| 2023-06-30 | 38.8 million | - | 4.8 million |
| 2023-03-31 | 47.3 million | - | 5.4 million |
| 2022-12-31 | 47.3 million | - | 5.9 million |
FRLN Shares Outstanding
FRLN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 6000 | 5.8 million | 6.4 million | - |
| 2023-06-30 | 256000 | 8.8 million | 9.5 million | - |
| 2023-03-31 | 3.9 million | 12.6 million | 5.6 million | - |
| 2022-12-31 | 3.9 million | 12.6 million | 5.6 million | - |
FRLN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 5000 | 383759 |
| 2023-06-30 | 617000 | 434392 |
| 2023-03-31 | - | 317360 |
| 2022-12-31 | - | - |
FRLN
Price: $6.49
52 week price:
Earnings Per Share: -11.45 USD
P/E Ratio: -0.56
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 189900
Market Capitalization: 28.2 million